Zhaoxiang Wang1, Li Zhang2, Fengyan Tang2, Zhongming Yang1, Mengzhu Wang1, Jue Jia1, Dong Wang1, Ling Yang1, Shao Zhong3, Guoyue Yuan4. 1. Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, China. 2. Department of Endocrinology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, 215300, China. 3. Department of Endocrinology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, 215300, China. drzhong@163.com. 4. Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, China. yuanguoyue@ujs.edu.cn.
Abstract
PURPOSE: Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease characterized by the destruction of pancreatic β cells. The goal of this study was to explore potential biological biomarkers for T1DM. METHODS: Two microarray datasets (GSE55098 and GSE156035) about human peripheral blood mononuclear cells (PBMCs) were systematically extracted from the Gene Expression Omnibus (GEO) database. Common genes were identified from the perspective of differentially expressed genes (DEGs) and weighted gene co-expression network analysis (WGCNA) respectively, and hub genes were identified by least absolute shrinkage and selection operator (LASSO) analysis. We also observed the expression of these hub genes in some common autoimmune diseases and predicted transcription factors (TFs) that might be associated with these genes. RESULTS: Seven hub genes (DDIT4, ESCO2, SH3BP4, PRICKLE1, EPM2AIP1, KCNJ15 and GRM8) were finally identified. Receiver operating characteristic (ROC) analysis showed that the high expression of these genes could well predict the occurrence of T1DM. Gene set enrichment analysis (GSEA) suggested that most of these hub genes may be mainly involved in the changes of biological functions such as inflammation, infection, immunity, cancer, and apoptosis. Further, compared with the control group, the expression levels of these hub genes also changed in some other autoimmune diseases, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), primary biliary cholangitis (PBC), etc., indicating that they might be the common targets of these autoimmune diseases. CONCLUSIONS: The present study identified novel genes associated with T1DM from the PBMCs perspective that might provide new ideas for the early diagnosis, monitoring, evaluation, and prediction of T1DM.
PURPOSE: Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease characterized by the destruction of pancreatic β cells. The goal of this study was to explore potential biological biomarkers for T1DM. METHODS: Two microarray datasets (GSE55098 and GSE156035) about human peripheral blood mononuclear cells (PBMCs) were systematically extracted from the Gene Expression Omnibus (GEO) database. Common genes were identified from the perspective of differentially expressed genes (DEGs) and weighted gene co-expression network analysis (WGCNA) respectively, and hub genes were identified by least absolute shrinkage and selection operator (LASSO) analysis. We also observed the expression of these hub genes in some common autoimmune diseases and predicted transcription factors (TFs) that might be associated with these genes. RESULTS: Seven hub genes (DDIT4, ESCO2, SH3BP4, PRICKLE1, EPM2AIP1, KCNJ15 and GRM8) were finally identified. Receiver operating characteristic (ROC) analysis showed that the high expression of these genes could well predict the occurrence of T1DM. Gene set enrichment analysis (GSEA) suggested that most of these hub genes may be mainly involved in the changes of biological functions such as inflammation, infection, immunity, cancer, and apoptosis. Further, compared with the control group, the expression levels of these hub genes also changed in some other autoimmune diseases, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), primary biliary cholangitis (PBC), etc., indicating that they might be the common targets of these autoimmune diseases. CONCLUSIONS: The present study identified novel genes associated with T1DM from the PBMCs perspective that might provide new ideas for the early diagnosis, monitoring, evaluation, and prediction of T1DM.
Authors: Sally C Kent; Yahua Chen; Sue M Clemmings; Vissia Viglietta; Norma Sue Kenyon; Camillo Ricordi; Bernhard Hering; David A Hafler Journal: J Immunol Date: 2005-10-01 Impact factor: 5.422
Authors: Roberto Bomprezzi; Markus Ringnér; Seungchan Kim; Michael L Bittner; Javed Khan; Yidong Chen; Abdel Elkahloun; Aimee Yu; Bibiana Bielekova; Paul S Meltzer; Roland Martin; Henry F McFarland; Jeffrey M Trent Journal: Hum Mol Genet Date: 2003-07-08 Impact factor: 6.150
Authors: Ellen C Kaizer; Casey L Glaser; Damien Chaussabel; Jacques Banchereau; Virginia Pascual; Perrin C White Journal: J Clin Endocrinol Metab Date: 2007-06-26 Impact factor: 5.958
Authors: Patrick A Ott; Beate R Berner; Bernhard A Herzog; Robert Guerkov; Nicole L Yonkers; Ivana Durinovic-Bello; Magdalena Tary-Lehmann; Paul V Lehmann; Donald D Anthony Journal: J Immunol Methods Date: 2004-02-15 Impact factor: 2.303
Authors: Partho Sen; Alex M Dickens; María Asunción López-Bascón; Tuomas Lindeman; Esko Kemppainen; Santosh Lamichhane; Tuukka Rönkkö; Jorma Ilonen; Jorma Toppari; Riitta Veijola; Heikki Hyöty; Tuulia Hyötyläinen; Mikael Knip; Matej Orešič Journal: Diabetologia Date: 2020-02-11 Impact factor: 10.122